X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sun Pharma with FDC LTD. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs FDC LTD. - Comparison Results

SUN PHARMA    Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA FDC LTD. SUN PHARMA/
FDC LTD.
 
P/E (TTM) x 23.2 20.6 112.6% View Chart
P/BV x 3.4 4.3 78.9% View Chart
Dividend Yield % 0.7 1.1 61.6%  

Financials

 SUN PHARMA   FDC LTD.
EQUITY SHARE DATA
    SUN PHARMA
Mar-17
FDC LTD.
Mar-14
SUN PHARMA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs842144 586.8%   
Low Rs57279 724.6%   
Sales per share (Unadj.) Rs131.647.6 276.7%  
Earnings per share (Unadj.) Rs32.77.6 429.8%  
Cash flow per share (Unadj.) Rs38.09.0 421.5%  
Dividends per share (Unadj.) Rs3.502.25 155.6%  
Dividend yield (eoy) %0.52.0 24.5%  
Book value per share (Unadj.) Rs152.747.5 321.3%  
Shares outstanding (eoy) m2,399.26177.83 1,349.2%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x5.42.3 229.7%   
Avg P/E ratio x21.614.6 147.9%  
P/CF ratio (eoy) x18.612.3 150.8%  
Price / Book Value ratio x4.62.3 197.9%  
Dividend payout %10.729.6 36.2%   
Avg Mkt Cap Rs m1,696,87719,784 8,577.2%   
No. of employees `00017.5NA-   
Total wages/salary Rs m49,0231,221 4,016.6%   
Avg. sales/employee Rs Th18,028.3NM-  
Avg. wages/employee Rs Th2,798.8NM-  
Avg. net profit/employee Rs Th4,479.5NM-  
INCOME DATA
Net Sales Rs m315,7848,459 3,733.3%  
Other income Rs m6,232394 1,583.4%   
Total revenues Rs m322,0168,852 3,637.8%   
Gross profit Rs m100,8932,070 4,873.7%  
Depreciation Rs m12,648249 5,077.3%   
Interest Rs m3,99831 12,892.6%   
Profit before tax Rs m90,4792,184 4,143.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m99-225 -44.2%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,116606 2,000.8%   
Profit after tax Rs m78,4621,353 5,798.5%  
Gross profit margin %31.924.5 130.5%  
Effective tax rate %13.427.7 48.3%   
Net profit margin %24.816.0 155.3%  
BALANCE SHEET DATA
Current assets Rs m329,5374,355 7,566.3%   
Current liabilities Rs m178,8701,792 9,982.2%   
Net working cap to sales %47.730.3 157.4%  
Current ratio x1.82.4 75.8%  
Inventory Days Days7944 177.7%  
Debtors Days Days8325 337.5%  
Net fixed assets Rs m204,7663,025 6,769.1%   
Share capital Rs m2,399179 1,343.4%   
"Free" reserves Rs m363,9978,243 4,416.1%   
Net worth Rs m366,3978,453 4,334.5%   
Long term debt Rs m14,36111 134,213.1%   
Total assets Rs m614,10210,557 5,817.0%  
Interest coverage x23.671.4 33.1%   
Debt to equity ratio x00 3,096.4%  
Sales to assets ratio x0.50.8 64.2%   
Return on assets %13.413.1 102.4%  
Return on equity %21.416.0 133.8%  
Return on capital %24.823.5 105.7%  
Exports to sales %013.3 0.0%   
Imports to sales %03.3 0.0%   
Exports (fob) Rs mNA1,126 0.0%   
Imports (cif) Rs mNA283 0.0%   
Fx inflow Rs m44,1181,146 3,849.4%   
Fx outflow Rs m24,484355 6,891.1%   
Net fx Rs m19,634791 2,482.8%   
CASH FLOW
From Operations Rs m70,8221,485 4,769.5%  
From Investments Rs m-42,216-620 6,814.5%  
From Financial Activity Rs m-22,854-753 3,037.1%  
Net Cashflow Rs m6,107113 5,413.7%  

Share Holding

Indian Promoters % 63.7 68.9 92.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.1 4.7 109.1%  
FIIs % 23.0 7.5 306.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.3 19.0 43.7%  
Shareholders   133,026 23,730 560.6%  
Pledged promoter(s) holding % 0.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   AJANTA PHARMA  GLENMARK PHARMA  ORCHID PHARMA LTD  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare SUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day Strong; Realty Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed buying activity throughout the day and ended the day on a strong note, albeit off the day's high.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

The Real Brave-hearts are Those Who Still Have Deposits in IDBI Bank(Vivek Kaul's Diary)

Nov 6, 2017

It makes no sense to continue banking with this bank.

'Buy and Hold Forever' Not The Best Investing Style After All(The 5 Minute Wrapup)

Nov 9, 2017

Even Buffett didn't always Buy and Hold forever. A look at Berkshire's 1992 and 2017 portfolios will tell you the story...

Large cap funds are more liquid(The Honest Truth)

Nov 6, 2017

Is the dangerous illiquidity risk in small-cap and mid-cap funds common to large-cap funds too?

You're Lucky You Missed Out on that IPO...(Smart Contrarian)

Nov 8, 2017

Here's how to profit from upcoming IPOs.

Your Last Chance to Trade ONLY the Best Stocks(Daily Profit Hunter)

Nov 11, 2017

Techno-Funda opportunities are knocking on your door. Are you ready to receive them?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Nov 17, 2017 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS